As we continue to evolve our brand to Cencora, you will continue to see visual changes. We will be sunsetting amerisourcebergen.com over time and are actively moving content and information over to cencora.com. Please visit cencora.com if you can't find what you are looking for here.

Visit Cencora

July 20, 2021

Podcast: Insulin biosimilars part 1

By AmerisourceBergen

In part one of a two-part series on insulin biosimilars, we’ll talk about what these new drugs could mean for the category.

You can also listen and subscribe wherever you get your podcasts, like Apple or Spotify.

Continue the conversation

Contact our biosimilars experts to learn more about our solutions for this important product category.

See our solutions

Topics:

Biosimilars Affordability Policy

Podcast: Insulin biosimilars part 2

AmerisourceBergen

Insulin consultation

Manufacturers

Report: Biosimilars usage is lowering costs for patients and the Medicare program

AmerisourceBergen

Man and a woman meet in an office

Manufacturers

Podcast: How 2023 will shape the US Biosimilar space for 2024 and beyond

AmerisourceBergen

Vials